These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6698886)

  • 1. The absolute structures of rubeomycins A and A1 (carminomycins II and III) and rubeomycins B and B1 (4-hydroxybaumycinols A1 and A2).
    Ogawa Y; Mori H; Yamada N; Kon K
    J Antibiot (Tokyo); 1984 Jan; 37(1):44-56. PubMed ID: 6698886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spatial configuration of the carbohydrate portion of carminomycins II and III].
    Spiridonova IA; Lomakina NN
    Antibiotiki; 1982 Apr; 27(4):258-63. PubMed ID: 6284023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure of carminomycins II and III].
    Zbarskiĭ VB; Potapova NP; Brazhnikova MG; Rozynov BV; Sibel'dina LA
    Antibiotiki; 1980 Jul; 25(7):488-92. PubMed ID: 6250460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure of the carbohydrate moiety of carminomycins II and III].
    Spiridonova IA; Lomakina NN; Vlasova TF
    Antibiotiki; 1980 Aug; 25(8):563-6. PubMed ID: 6250463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubeomycin, a new anthracycline antibiotic complex. I. Taxonomy of producing organism, isolation, characterization and biological activities of rubeomycin A, A1, B and B1.
    Ogawa Y; Sugi H; Fujikawa N; Mori H
    J Antibiot (Tokyo); 1981 Aug; 34(8):938-50. PubMed ID: 7319927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial transformation of rubeomycin A to rubeomycin B.
    Ogawa Y; Mizukoshi S; Mori H
    J Antibiot (Tokyo); 1983 Nov; 36(11):1561-3. PubMed ID: 6686224
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of anthracyclines with covalently closed circular DNA.
    Mong S; DuVernay VH; Strong JE; Crooke ST
    Mol Pharmacol; 1980 Jan; 17(1):100-4. PubMed ID: 6155600
    [No Abstract]   [Full Text] [Related]  

  • 8. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synthesis and properties of the N-ethyl derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Povarov LS; Potapova NP
    Antibiotiki; 1982; 27(7):488-93. PubMed ID: 6814352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production of 14-substituted derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Povarov LS; Salimova KI; Potapova NP
    Antibiotiki; 1982 Oct; 27(10):732-7. PubMed ID: 7149678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and mass-spectrometric analysis of N-cycloalkyl derivatives of carminomycin, daunorubicin and their analogs].
    Olsuf'eva EN; Rozynov BV
    Bioorg Khim; 1990 Jun; 16(6):847-53. PubMed ID: 2222529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-beam light absorption measurement of anthracyclines in cells with a flow-through system.
    Lankelma J; Koopman G; van Grondelle R; Pinedo HM
    Biochim Biophys Acta; 1988 Feb; 964(2):200-6. PubMed ID: 3422571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial conversion of anthracyclinones to carminomycins by a blocked mutant of Actinomadura roseoviolacea.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1989 Nov; 42(11):1698-703. PubMed ID: 2584152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor properties of 7-deoxy-7-[(cis- and trans-3-aminocyclohexane)thio]carminomycinone.
    Essery JM; Doyle TW; Schreiber RH
    J Med Chem; 1979 Nov; 22(11):1425-8. PubMed ID: 160462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin].
    Povarov LS; Isaeva NN
    Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2'-deoxy-L-fucopyranosylcarminomycinone and -epsilon-pyrromycinone as well as 2'-deoxy-D-erythro-pentopyranosyldaunomycinone, -carminomycinone, and -epsilon-pyrromycinone.
    El Khadem HS; Swartz DL
    J Med Chem; 1981 Jan; 24(1):112-5. PubMed ID: 7205866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of epsilon-rhodomycinone- and carminomycin-11-methyl ethers.
    Essery JM; Doyle TW
    J Antibiot (Tokyo); 1979 Mar; 32(3):247-9. PubMed ID: 457585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic properties of three anthracyclines as a function of lipophilicity.
    Kessel D
    Biochem Pharmacol; 1979 Oct; 28(19):3028-30. PubMed ID: 518699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.